Abstract
Sensorineural hearing loss is a complex disease state influenced by genetics, age, noise, and many other factors. This article reviews our current knowledge regarding the causes of sensorineural hearing loss and reviews the more challenging clinical presentations of sensorineural hearing loss. We have reviewed the latest medical literature in an attempt to provide an evidence-based strategy for the assessment and management of sudden sensorineural hearing loss, rapidly progressive sensorineural hearing loss, and asymmetric/unilateral sensorineural hearing loss.
Copyright © 2012 Elsevier Inc. All rights reserved.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use*
-
Adult
-
Age Factors
-
Anti-Inflammatory Agents / therapeutic use
-
Antineoplastic Agents, Alkylating / therapeutic use
-
Antiviral Agents / therapeutic use*
-
Audiometry, Pure-Tone / methods*
-
Autoimmune Diseases / complications
-
Disease Management
-
Drug Administration Routes
-
Evidence-Based Practice*
-
Evoked Potentials, Auditory
-
Hearing Loss, Sensorineural* / diagnosis
-
Hearing Loss, Sensorineural* / etiology
-
Hearing Loss, Sensorineural* / physiopathology
-
Hearing Loss, Sensorineural* / therapy
-
Humans
-
Hyperbaric Oxygenation / methods
-
Inheritance Patterns
-
Neuroma, Acoustic / complications
-
Noise / adverse effects
-
Plasmapheresis / methods*
-
Speech Discrimination Tests / methods*
-
Time-to-Treatment
-
Tomography, X-Ray Computed / methods
-
Virus Diseases / complications
Substances
-
Adrenal Cortex Hormones
-
Anti-Inflammatory Agents
-
Antineoplastic Agents, Alkylating
-
Antiviral Agents